The effect of surface modification and aprotinin on cellular injury during simulated cardiopulmonary bypass

Benjamin L. Greenfield, Kelly R. Brinkman, Kelly L. Koziol, Martin W. McCann, Kellie A. Merrigan, Lee P. Steffen, Kylie A. Woods, Alfred H. Stammers, Lynette M Smith

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Cardiopulmonary bypass (CPB) elicits derangements to the formed elements of blood because of the physical stresses of extracorporeal flow. Methods of reducing the impact of CPB include circuit surface modification and pharmacological supplementation. The purpose of this study was to examine the effects of aprotinin in combination with surface modification during simulated CPB. Fresh whole bovine blood was used to prime standard CPB circuits divided into four groups (N = 3): control (CTR), aprotinin 300 KIU/mL (APR), Poly (2-methoxyethylacrylate) coating (PMEA), and APR with PMEA (APRPMEA). Physical stresses included venous reservoir negative pressure (-85 mmHg), arterial line pressure of 150 mmHg at 5 LPM, and air-blood interface, applied over a 90-minute period. Samples were drawn at the following times: 0, 10, 45, and 90 minutes. Endpoints included platelet count (PLT), plasma-free hemoglobin (PFHb), and thromboelastography (TEG). PLT did not change (138.9 ± 15.0 vs. 102.9 ± 21.0, p = ns) throughout the 90-minute experimental periods in any group. PFHb increased significantly (mean of 19-fold) throughout the experiment, but was not affected by any treatment. The TEG index declined in the CTR (3.6 ± 0.4 vs. -16.2 ± 2.9, p < .0003), PMEA (5.9 ± 0.8 vs. -2.7 ± 3.8, p < .02), and APR-PMEA (4.6 ± 1.0 vs. -2.8 ± 0.3 p < .0003) groups, but not in the APR group (3.6 ± 2.2 vs. -1.3 ± 3.3 p = .10). In conclusion, neither APR nor PMEA had an effect on either red cell hemolysis or PLT, but APR treatment alone significantly attenuated the derangements in coagulation induced in this extracorporeal model.

Original languageEnglish (US)
Pages (from-to)267-270
Number of pages4
JournalJournal of Extra-Corporeal Technology
Volume34
Issue number4
StatePublished - Dec 1 2002

Fingerprint

Aprotinin
Cardiopulmonary Bypass
Platelet Count
Wounds and Injuries
Thrombelastography
Vascular Access Devices
Hemoglobins
Hemolysis
Arterial Pressure
Cell Count
Air
poly(2-methoxyethylacrylate)
Pharmacology
Pressure

Keywords

  • Aprotinin
  • Biocompatibility
  • Cardiopulmonary bypass
  • Cellular activation
  • Suction

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Greenfield, B. L., Brinkman, K. R., Koziol, K. L., McCann, M. W., Merrigan, K. A., Steffen, L. P., ... Smith, L. M. (2002). The effect of surface modification and aprotinin on cellular injury during simulated cardiopulmonary bypass. Journal of Extra-Corporeal Technology, 34(4), 267-270.

The effect of surface modification and aprotinin on cellular injury during simulated cardiopulmonary bypass. / Greenfield, Benjamin L.; Brinkman, Kelly R.; Koziol, Kelly L.; McCann, Martin W.; Merrigan, Kellie A.; Steffen, Lee P.; Woods, Kylie A.; Stammers, Alfred H.; Smith, Lynette M.

In: Journal of Extra-Corporeal Technology, Vol. 34, No. 4, 01.12.2002, p. 267-270.

Research output: Contribution to journalArticle

Greenfield, BL, Brinkman, KR, Koziol, KL, McCann, MW, Merrigan, KA, Steffen, LP, Woods, KA, Stammers, AH & Smith, LM 2002, 'The effect of surface modification and aprotinin on cellular injury during simulated cardiopulmonary bypass', Journal of Extra-Corporeal Technology, vol. 34, no. 4, pp. 267-270.
Greenfield BL, Brinkman KR, Koziol KL, McCann MW, Merrigan KA, Steffen LP et al. The effect of surface modification and aprotinin on cellular injury during simulated cardiopulmonary bypass. Journal of Extra-Corporeal Technology. 2002 Dec 1;34(4):267-270.
Greenfield, Benjamin L. ; Brinkman, Kelly R. ; Koziol, Kelly L. ; McCann, Martin W. ; Merrigan, Kellie A. ; Steffen, Lee P. ; Woods, Kylie A. ; Stammers, Alfred H. ; Smith, Lynette M. / The effect of surface modification and aprotinin on cellular injury during simulated cardiopulmonary bypass. In: Journal of Extra-Corporeal Technology. 2002 ; Vol. 34, No. 4. pp. 267-270.
@article{7aa7fa816ddd4bda81fd85df32a1357a,
title = "The effect of surface modification and aprotinin on cellular injury during simulated cardiopulmonary bypass",
abstract = "Cardiopulmonary bypass (CPB) elicits derangements to the formed elements of blood because of the physical stresses of extracorporeal flow. Methods of reducing the impact of CPB include circuit surface modification and pharmacological supplementation. The purpose of this study was to examine the effects of aprotinin in combination with surface modification during simulated CPB. Fresh whole bovine blood was used to prime standard CPB circuits divided into four groups (N = 3): control (CTR), aprotinin 300 KIU/mL (APR), Poly (2-methoxyethylacrylate) coating (PMEA), and APR with PMEA (APRPMEA). Physical stresses included venous reservoir negative pressure (-85 mmHg), arterial line pressure of 150 mmHg at 5 LPM, and air-blood interface, applied over a 90-minute period. Samples were drawn at the following times: 0, 10, 45, and 90 minutes. Endpoints included platelet count (PLT), plasma-free hemoglobin (PFHb), and thromboelastography (TEG). PLT did not change (138.9 ± 15.0 vs. 102.9 ± 21.0, p = ns) throughout the 90-minute experimental periods in any group. PFHb increased significantly (mean of 19-fold) throughout the experiment, but was not affected by any treatment. The TEG index declined in the CTR (3.6 ± 0.4 vs. -16.2 ± 2.9, p < .0003), PMEA (5.9 ± 0.8 vs. -2.7 ± 3.8, p < .02), and APR-PMEA (4.6 ± 1.0 vs. -2.8 ± 0.3 p < .0003) groups, but not in the APR group (3.6 ± 2.2 vs. -1.3 ± 3.3 p = .10). In conclusion, neither APR nor PMEA had an effect on either red cell hemolysis or PLT, but APR treatment alone significantly attenuated the derangements in coagulation induced in this extracorporeal model.",
keywords = "Aprotinin, Biocompatibility, Cardiopulmonary bypass, Cellular activation, Suction",
author = "Greenfield, {Benjamin L.} and Brinkman, {Kelly R.} and Koziol, {Kelly L.} and McCann, {Martin W.} and Merrigan, {Kellie A.} and Steffen, {Lee P.} and Woods, {Kylie A.} and Stammers, {Alfred H.} and Smith, {Lynette M}",
year = "2002",
month = "12",
day = "1",
language = "English (US)",
volume = "34",
pages = "267--270",
journal = "Journal of Extra-Corporeal Technology",
issn = "0022-1058",
publisher = "American Society of Extra-Corporeal Technology",
number = "4",

}

TY - JOUR

T1 - The effect of surface modification and aprotinin on cellular injury during simulated cardiopulmonary bypass

AU - Greenfield, Benjamin L.

AU - Brinkman, Kelly R.

AU - Koziol, Kelly L.

AU - McCann, Martin W.

AU - Merrigan, Kellie A.

AU - Steffen, Lee P.

AU - Woods, Kylie A.

AU - Stammers, Alfred H.

AU - Smith, Lynette M

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Cardiopulmonary bypass (CPB) elicits derangements to the formed elements of blood because of the physical stresses of extracorporeal flow. Methods of reducing the impact of CPB include circuit surface modification and pharmacological supplementation. The purpose of this study was to examine the effects of aprotinin in combination with surface modification during simulated CPB. Fresh whole bovine blood was used to prime standard CPB circuits divided into four groups (N = 3): control (CTR), aprotinin 300 KIU/mL (APR), Poly (2-methoxyethylacrylate) coating (PMEA), and APR with PMEA (APRPMEA). Physical stresses included venous reservoir negative pressure (-85 mmHg), arterial line pressure of 150 mmHg at 5 LPM, and air-blood interface, applied over a 90-minute period. Samples were drawn at the following times: 0, 10, 45, and 90 minutes. Endpoints included platelet count (PLT), plasma-free hemoglobin (PFHb), and thromboelastography (TEG). PLT did not change (138.9 ± 15.0 vs. 102.9 ± 21.0, p = ns) throughout the 90-minute experimental periods in any group. PFHb increased significantly (mean of 19-fold) throughout the experiment, but was not affected by any treatment. The TEG index declined in the CTR (3.6 ± 0.4 vs. -16.2 ± 2.9, p < .0003), PMEA (5.9 ± 0.8 vs. -2.7 ± 3.8, p < .02), and APR-PMEA (4.6 ± 1.0 vs. -2.8 ± 0.3 p < .0003) groups, but not in the APR group (3.6 ± 2.2 vs. -1.3 ± 3.3 p = .10). In conclusion, neither APR nor PMEA had an effect on either red cell hemolysis or PLT, but APR treatment alone significantly attenuated the derangements in coagulation induced in this extracorporeal model.

AB - Cardiopulmonary bypass (CPB) elicits derangements to the formed elements of blood because of the physical stresses of extracorporeal flow. Methods of reducing the impact of CPB include circuit surface modification and pharmacological supplementation. The purpose of this study was to examine the effects of aprotinin in combination with surface modification during simulated CPB. Fresh whole bovine blood was used to prime standard CPB circuits divided into four groups (N = 3): control (CTR), aprotinin 300 KIU/mL (APR), Poly (2-methoxyethylacrylate) coating (PMEA), and APR with PMEA (APRPMEA). Physical stresses included venous reservoir negative pressure (-85 mmHg), arterial line pressure of 150 mmHg at 5 LPM, and air-blood interface, applied over a 90-minute period. Samples were drawn at the following times: 0, 10, 45, and 90 minutes. Endpoints included platelet count (PLT), plasma-free hemoglobin (PFHb), and thromboelastography (TEG). PLT did not change (138.9 ± 15.0 vs. 102.9 ± 21.0, p = ns) throughout the 90-minute experimental periods in any group. PFHb increased significantly (mean of 19-fold) throughout the experiment, but was not affected by any treatment. The TEG index declined in the CTR (3.6 ± 0.4 vs. -16.2 ± 2.9, p < .0003), PMEA (5.9 ± 0.8 vs. -2.7 ± 3.8, p < .02), and APR-PMEA (4.6 ± 1.0 vs. -2.8 ± 0.3 p < .0003) groups, but not in the APR group (3.6 ± 2.2 vs. -1.3 ± 3.3 p = .10). In conclusion, neither APR nor PMEA had an effect on either red cell hemolysis or PLT, but APR treatment alone significantly attenuated the derangements in coagulation induced in this extracorporeal model.

KW - Aprotinin

KW - Biocompatibility

KW - Cardiopulmonary bypass

KW - Cellular activation

KW - Suction

UR - http://www.scopus.com/inward/record.url?scp=0036982704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036982704&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 267

EP - 270

JO - Journal of Extra-Corporeal Technology

JF - Journal of Extra-Corporeal Technology

SN - 0022-1058

IS - 4

ER -